Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2

Tjerk S. J. Opstal; Amber van Broekhoven; Aernoud T. L. Fiolet; Arend Mosterd; John W. Eikelboom; Stefan M. Nidorf; Peter L. Thompson; Charley A. Budgeon; Louis Bartels; Ron de Nooijer; Willem A. Bax; Jan G. P. Tijssen; Saloua el Messaoudi; Jan H. Cornel

doi:https://doi.org/10.1161/CIRCULATIONAHA.121.058233

Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2

Tjerk S. J. Opstal, Amber van Broekhoven, Aernoud T. L. Fiolet, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, Peter L. Thompson, Charley A. Budgeon, Louis Bartels, Ron de Nooijer, Willem A. Bax, Jan G. P. Tijssen, Saloua el Messaoudi, Jan H. Cornel

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	626-628
Number of pages	3
Journal	Circulation
Volume	145
Issue number	8
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.121.058233
Publication status	Published - 22 Feb 2022

Keywords

cardiovascular diseases
colchicine
coronary artery disease
inflammation

Access to Document

https://doi.org/10.1161/CIRCULATIONAHA.121.058233

Cite this

Opstal, T. S. J., van Broekhoven, A., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Nidorf, S. M., Thompson, P. L., Budgeon, C. A., Bartels, L., de Nooijer, R., Bax, W. A., Tijssen, J. G. P., el Messaoudi, S., & Cornel, J. H. (2022). Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2. Circulation, 145(8), 626-628. https://doi.org/10.1161/CIRCULATIONAHA.121.058233

@article{693219642c52417cb9f1af9e9b68e6cd,

title = "Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2",

keywords = "cardiovascular diseases, colchicine, coronary artery disease, inflammation",

author = "Opstal, {Tjerk S. J.} and {van Broekhoven}, Amber and Fiolet, {Aernoud T. L.} and Arend Mosterd and Eikelboom, {John W.} and Nidorf, {Stefan M.} and Thompson, {Peter L.} and Budgeon, {Charley A.} and Louis Bartels and {de Nooijer}, Ron and Bax, {Willem A.} and Tijssen, {Jan G. P.} and {el Messaoudi}, Saloua and Cornel, {Jan H.}",

note = "Funding Information: This trial was supported by the National Health Medical Research Council of Australia, a grant from the Sir Charles Gairdner Research Advisory Committee, the Withering Foundation, The Netherlands, The Netherlands Heart Foundation, The Netherlands Organization for Health Research and Development, and a consortium of Teva, Disphar, and Tiofarma in The Netherlands. The funders did not have any role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the article. Funding Information: A.M. reports grants from Novartis and personal fees from Amarin, Amgen, BMS, Boehringer Ingelheim, MSD, and Pfizer. J.W.E. reports consulting/honoraria support from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Pfizer, Janssen, Sanofi-Aventis, and Servier, and grants or in-kind support from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Janssen, and Sanofi-Aventis. P.L.T. reports grants, travel support, and honoraria from Amarin, Amgen, AstraZeneca, Bristol Myers Squibb, Merck, and Pfizer. J.H.C. reports membership on advisory boards for Amgen and AstraZeneca. The other authors report no conflicts.",

year = "2022",

month = feb,

day = "22",

doi = "https://doi.org/10.1161/CIRCULATIONAHA.121.058233",

language = "English",

volume = "145",

pages = "626--628",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "8",

}

Opstal, TSJ, van Broekhoven, A, Fiolet, ATL, Mosterd, A, Eikelboom, JW, Nidorf, SM, Thompson, PL, Budgeon, CA, Bartels, L, de Nooijer, R, Bax, WA, Tijssen, JGP, el Messaoudi, S & Cornel, JH 2022, 'Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2', Circulation, vol. 145, no. 8, pp. 626-628. https://doi.org/10.1161/CIRCULATIONAHA.121.058233

TY - JOUR

T1 - Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease

T2 - Insights From LoDoCo2

AU - Opstal, Tjerk S. J.

AU - van Broekhoven, Amber

AU - Fiolet, Aernoud T. L.

AU - Mosterd, Arend

AU - Eikelboom, John W.

AU - Nidorf, Stefan M.

AU - Thompson, Peter L.

AU - Budgeon, Charley A.

AU - Bartels, Louis

AU - de Nooijer, Ron

AU - Bax, Willem A.

AU - Tijssen, Jan G. P.

AU - el Messaoudi, Saloua

AU - Cornel, Jan H.

N1 - Funding Information: This trial was supported by the National Health Medical Research Council of Australia, a grant from the Sir Charles Gairdner Research Advisory Committee, the Withering Foundation, The Netherlands, The Netherlands Heart Foundation, The Netherlands Organization for Health Research and Development, and a consortium of Teva, Disphar, and Tiofarma in The Netherlands. The funders did not have any role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the article. Funding Information: A.M. reports grants from Novartis and personal fees from Amarin, Amgen, BMS, Boehringer Ingelheim, MSD, and Pfizer. J.W.E. reports consulting/honoraria support from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Pfizer, Janssen, Sanofi-Aventis, and Servier, and grants or in-kind support from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Janssen, and Sanofi-Aventis. P.L.T. reports grants, travel support, and honoraria from Amarin, Amgen, AstraZeneca, Bristol Myers Squibb, Merck, and Pfizer. J.H.C. reports membership on advisory boards for Amgen and AstraZeneca. The other authors report no conflicts.

PY - 2022/2/22

Y1 - 2022/2/22

KW - cardiovascular diseases

KW - colchicine

KW - coronary artery disease

KW - inflammation

UR - http://www.scopus.com/inward/record.url?scp=85125002907&partnerID=8YFLogxK

U2 - https://doi.org/10.1161/CIRCULATIONAHA.121.058233

DO - https://doi.org/10.1161/CIRCULATIONAHA.121.058233

M3 - Article

C2 - 35188792

SN - 0009-7322

VL - 145

SP - 626

EP - 628

JO - Circulation

JF - Circulation

IS - 8

ER -

Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2

Keywords

Access to Document

Other files and links

Cite this